Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Asthma Therapeutics Market

Asthma Therapeutics Market Share

Report ID: GMI8394
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Asthma Therapeutics Market Share

The asthma therapeutics industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness are among a key market strategy for asthma therapeutics product manufacturers. Some of the leading industry players including AstraZeneca, Boehringer Ingelheim GSK plc, and Merck & Co., Inc., among others have a substantial presence in the market.

Asthma Therapeutics Market Companies

Some of the eminent market participants operating in the asthma therapeutics industry include:

AstraZeneca
Boehringer Ingelheim
Cipla Ltd.
Covis Pharma
GSK plc
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Regeneron Pharmaceuticals, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global asthma therapeutics industry size was USD 25.7 billion in 2023 and is estimated to reach USD 37.8 billion by 2032, attributed to the growing prevalence of asthma and rising expenditure on the R&D of novel biologics.

The long-term asthma control medications treatment type segment in the market reached over USD 14.8 billion in 2023 and is poised to grow rapidly by 2032, due to their role to provide management of symptoms for ensuring sustained relief for individuals with asthma.

North America asthma therapeutics industry accounted for USD 10.2 billion in revenue in 2023 and is predicted to witness substantial growth over 2024 to 2032, driven by a robust healthcare infrastructure and extensive R&D initiatives.

AstraZeneca, Boehringer Ingelheim, Cipla Ltd., Covis Pharma, GSK plc, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Teva Pharmaceutical Industries Ltd. are some of the major industry contenders.